Breakthrough T1D Launches Third Center of Excellence in New England
The Breakthrough T1D New England Center of Excellence will focus on protecting the stem cell-derived beta cells from rejection by…
She Had a Wish: Donate to Science
When Cheryl Diderich died, her husband knew she wanted to live on through his gift of $1.2 million to Breakthrough…
T1D Voices: Reagan’s Story Is Our Story
T1D Champion Reagan Moore shares her T1D journey, her hopes for the future, and why she loves her insulin pump.
Can a Psoriasis Drug Halt or Reverse Type 1 Diabetes?
Type 1 diabetes is one of the only major autoimmune diseases that doesn't have a disease-modifying therapy. A Breakthrough T1D clinical…
Vertex Has a New Horizon: Curing Type 1 Diabetes
Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).
Timothy Doyle Joins Breakthrough T1D as President and Chief Operating Officer
Doyle will lead organizational operations to broaden Breakthrough T1D’s reach and impact.
